undamentalytics Newsletter

Kalra Balkrishan: insider trades

Chief executive, Officer at Genpact LTD. No open-market purchases and 18 sales not made under a pre-set plan, reported from August 23, 2019 to September 16, 2026.

What happened after Kalra Balkrishan’s sales?

After their sales, the shares moved −24.3% against the index over 12 months on average (a negative figure means selling was the right call); 88% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Kalra Balkrishan: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 17 −7.2% −5.2% 82% 7 −1.12 0.31 No reliable evidence
Sales, 12 months after the report 16 −24.3% −20.1% 88% 6 −3.41 0.019 Some evidence: seller right
Sales, 12 months after the trade 16 −24.8% −19.0% 88% 6 −3.59 0.016 Some evidence: seller right

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Genpact LTD G President and CEO018August 23, 2019September 16, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
September 16, 2026September 14, 2026 G Sale $367,900 not yetnot yetnot yet
March 5, 2026March 4, 2026 G Sale $114,156 −31.4%not yetnot yet
September 15, 2025September 11, 2025 G Sale $2,384,850 +11.1%−30.9%−31.5%
November 26, 2024November 25, 2024 G Sale $417,600 +16.1%−19.0%−19.9%
September 13, 2024September 12, 2024 G Sale $269,780 +7.2%−11.7%−10.6%
March 15, 2023March 13, 2023 G Sale $989,232 −22.3%−55.1%−58.6%
March 8, 2023March 6, 2023 G Sale $946,685 −28.4%−57.5%−55.1%
February 23, 2023February 21, 2023 G Sale $1,199,750 −26.4%−54.2%−52.5%
September 9, 2022September 7, 2022 G Sale $495,405 −1.0%−31.9%−32.9%
September 7, 2022September 2, 2022 G Sale $413,802 −2.4%−33.2%−33.7%
August 30, 2022August 26, 2022 G Sale $473,500 −5.2%−34.5%−31.1%
December 15, 2021December 13, 2021 G Sale $253,650 −7.7%+6.2%+2.7%
September 16, 2021September 15, 2021 G Sale $250,900 −2.5%+4.8%+2.1%
March 16, 2021March 12, 2021 G Sale $42,800 −1.9%−8.7%−10.9%
March 12, 2021March 10, 2021 G Sale $133,667 −1.7%−9.2%−12.4%
September 3, 2019August 30, 2019 G Sale $409,700 −8.8%−21.1%−17.9%
August 29, 2019August 27, 2019 G Sale $1,216,142 −8.4%−17.9%−18.1%
August 23, 2019August 21, 2019 G Sale $1,526,222 −8.8%−15.4%−16.2%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Kalra Balkrishan traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.